DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business.

DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Elizabeth Anderson - Evercore Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Brandon Couillard - Jefferies Jeffrey Johnson - Baird Daniel Clark - Bank of America Jonathan Block - Stifel Michael Petusky - Barrington Research Jason Bednar - Piper Sandler Brandon Vazquez - William Blair Operator Good day, and welcome to the Dentsply Sirona Q3 2022 Earnings Conference Call. All participants will be listen-only mode.

DENTSPLY SIRONA Inc. (XRAY) Q3 2022 Earnings Call Transcript

CHARLOTTE, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2022.

Dentsply Sirona Reports Third Quarter 2022 Results

CHARLOTTE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Monday, November 14, 2022, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host Third Quarter Conference Call on November 14th

DENTSPLY SIRONA's (XRAY) third-quarter results are likely to reflect strong performance in the Technologies & Equipment business.

What's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings?

New York, New York--(Newsfile Corp. - November 1, 2022) - Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Dentsply Sirona Inc. ("Dentsply") (NASDAQ: XRAY) breached their fiduciary duties to Dentsply and its shareholders.

Dentsply Sirona Stock (XRAY) - Dentsply Sirona Shareholders Who Have Held Their Stock Since At Least April 2022 Encouraged To Contact Kehoe Law Firm

Dentsply Sirona Inc. XRAY, -0.13% , a maker of dental products and technology, said Tuesday it has completed an internal probe of financial reporting involving former and current executives and said it would restate third-quarter and full-year 2021 earnings. The probe looked at allegations of "channel stuffing", a deceptive practice used to inflate sales and earnings by deliberately sending more product to distributors than they can reasonably sell.

Dentsply Sirona completes internal probe of accounting; to restate Q3 and full-year 2021 earnings and book up to $1.3 billion goodwill charge

Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials

Dentsply Sirona Completes Internal Investigation

Align Technology

SmileDirectClub

The orthodontic treatment market has experienced substantial recovery, primarily owing to the easing of restrictions and mass opening up of the economy in 2022.

3 Stocks From the Growing Digital Orthodontic Space in Focus

CHARLOTTE, N.C., Sept. 22, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Glenn Coleman has been appointed Executive Vice President and Chief Financial Officer, effective September 26, 2022. He succeeds Barbara Bodem, who has served as Interim Chief Financial Officer since May 2022. Ms. Bodem will remain with the company and continue to serve as an advisor to Mr. Coleman until October 24, 2022.

Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer

Dentsply Sirona launches new digital dentistry solutions at DS World 2022 in Las Vegas that enable long-term practice growth by increasing efficiency, introducing new procedures and treatment workflows, and improving patient outcomes. Superior intraoral scanner Primescan now available as laptop-based solution, Primescan Connect – an easy starting point in digital dentistry.

Dentsply Sirona Extends Its Digital Universe with Primescan Connect

New York, New York--(Newsfile Corp. - September 14, 2022) - Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Dentsply Sirona Inc. ("Dentsply") (NASDAQ: XRAY) breached their fiduciary duties to Dentsply and its shareholders.

Dentsply Sirona Stock: Dentsply Sirona Shareholders (XRAY) Are Encouraged To Contact Kehoe Law Firm, P.C. To Discuss Potential Legal Claims

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Dentsply Sirona Inc. (“Dentsply”) (NASDAQ: XRAY) breached their fiduciary duties to Dentsply and its shareholders. If you are a Dentsply shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or jpettigrew@scott-scott.com. Scott+Scott is investigat

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Dentsply Sirona Inc.'s Directors and Officers for Breach of Fiduciary Duties – XRAY

CHARLOTTE, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Simon Campion has been appointed President and Chief Executive Officer and will join the Company's Board of Directors (“Board”), effective September 12, 2022. He succeeds John Groetelaars, who has served as Interim Chief Executive Officer since April 2022. Mr. Groetelaars will continue to serve on the Board.

Dentsply Sirona Appoints Simon Campion as Chief Executive Officer

The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.

DENTSPLY SIRONA (XRAY) Falls After Nasdaq's Delinquency Notice

CHARLOTTE, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that, as expected, it received written notification from The NASDAQ Stock Market (“Nasdaq”) on August 12, 2022 that the Company remains out of compliance with the Nasdaq Listing Rules because the Company has not yet filed its Quarterly Reports on Form 10-Q for the periods ended March 31, 2022 and June 30, 2022 (individually the “First Quarter 10-Q” and “Second Quarter 10-Q,” respectively, and together, the “Quarterly Reports”). Nasdaq Listing Rule 5250(c)(1) requires Nasdaq-listed companies to timely file all periodic reports.

Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq

DENTSPLY SIRONA's (XRAY) preliminary second-quarter 2022 results reflect the normalizing business, aided by product launches and pricing adjustments. Shares rise.

DENTSPLY SIRONA (XRAY) Up on Strong Q2 Preliminary Results

Company Provides Select Preliminary Second Quarter 2022 Results

Dentsply Sirona Provides Business Update

New York, New York--(Newsfile Corp. - July 30, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022 lead plaintiff deadline.

XRAY FINAL DEADLINE MONDAY: ROSEN, A LEADING NATIONAL FIRM, Encourages DENTSPLY SIRONA Inc. Investors to Secure Counsel Before Important August 1 Deadline in Securities Class Action - XRAY

NEW YORK , July 29, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022 lead plaintiff deadline. SO WHAT: If you purchased Dentsply common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

XRAY FINAL DEADLINE AUGUST 1: ROSEN, A LONGSTANDING LAW FIRM, Encourages DENTSPLY SIRONA Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action - XRAY

CEDARHURST, N.Y. , July 27, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Dentsply Sirona, Inc. (NasdaqGS: XRAY), if they purchased the Company's shares between June 9, 2021 and May 9, 2022, inclusive (the "Class Period").

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of Dentsply Sirona, Inc. - XRAY

NEW YORK , July 27, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc.. Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Dentsply Sirona Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2022 - (NASDAQ: XRAY)

New York, New York--(Newsfile Corp. - July 26, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022, both dates inclusive (the "Class Period"), of the important August 1, 2022 lead plaintiff deadline.

XRAY FINAL DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DENTSPLY SIRONA Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class Action - XRAY

NEW YORK , July 26, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY) alleging that the Company violated federal securities laws. This lawsuit is on behalf of all persons or entities that purchased Dentsply's common stock between June 9, 2021, and May 9, 2022.Lead Plaintiff Deadline: August 1, 2022 No obligation or cost to you.

XRAY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 1, 2022 in the Class Action Filed on Behalf of Dentsply Sirona Inc. Shareholders

NEW YORK , July 25, 2022 /PRNewswire/ -- Attention Dentsply Sirona Inc. ("Dentsply") (NASDAQ: XRAY) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of all persons or entities that purchased Dentsply's common stock between June 9, 2021, and May 9, 2022.

News for DENTSPLY SIRONA Stock (XRAY)